Gene Therapy Shows Early Promise as Angelman Syndrome Treatment October 25, 2021 By Sue Modlin Full details of the announcement can be found on the 黑料网 Health and 黑料网 Newsroom . Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition in animal models. Filed Under: Categories: News More from 黑料网 Neuroscience Center Advancing Brain Research: The Frohlich Lab’s Work in Neurostimulation and Mental Health 黑料网 Neuroscience Faculty Receive BBRF Distinguished Investigator Grants FDA Grants Breakthrough Device Designation for Non-Invasive Brain Stimulation Device to Treat Major Depressive Disorder